By inhibiting the NLRP3/caspase-1/IL-1β pathway, it diminished p38 phosphorylation, facilitating the restoration of Cx43 expression and mitigating cardiac electrical remodeling post-MI, consequently lowering cardiac susceptibility to VAs and the occurrence of HF (122). This evidence concerns the gene NLRP3 and myocardial infarction.